HAEMONETICS CORP — Director's Dealing 2010

Oct 29, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-10-27

Reporting Person: FORISH JOSEPH J (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-27	Common Stock	A	1773.0000	$0.0100	Acquired	6332.0000	Direct
2010-10-28	Common Stock	D	60.0000	$55.1900	Disposed	6272.0000	Direct
2010-10-28	Common Stock	D	59.0000	$55.1900	Disposed	6213.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-27	Non-Qualified Stock Option (right to buy)	$54.9900	A	15388.0000	Acquired	2017-10-27	Common Stock (15388)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$48.1950	2012-12-19	Common Stock (75000)	75000.0000	Direct
Non-Qualified Stock Option (right to buy)	$51.0700	2014-10-24	Common Stock (11799)	11799.0000	Direct
Non-Qualified Stock Option (right to buy)	$52.7600	2013-05-05	Common Stock (10373)	10373.0000	Direct
Non-Qualified Stock Option (right to buy)	$52.9400	2016-10-27	Common Stock (14690)	14690.0000	Direct
Non-Qualified Stock Option (right to buy)	$54.5500	2015-10-22	Common Stock (11911)	11911.0000	Direct

Footnotes

F1: Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F3: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.

F4: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.